Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Are These Five Stocks in Spotlight on Monday?

The Crackdown on Tax Inversions Claims Another Victim

CF Industries Holdings, Inc. (NYSE:CF) is 3.50% higher today after the company called off a $8 billion deal to acquire several key assets of OCI of the Netherlands. CF Industries changed its mind principally because the acquisitions didn’t make as much sense after the U.S. changed its laws concerning tax inversions. Investors are applauding because some pockets of the sector are in oversupply and expanding capacity at a time of sector weakness was not a sure bet. The number of funds from our database with holdings in CF Industries Holdings, Inc. (NYSE:CF) fell by five quarter-over-quarter to 32 at the end of March.

Follow Cf Industries Holdings Inc. (NYSE:CF)
Trade (NYSE:CF) Now!

Valeant Management Reshuffle Continues

Last but not least, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is slightly higher in the pre-market after the company’s senior vice president of neurology, dentistry, and genetics resigned to pursue other opportunities. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) recently shuffled its board of directors and installed a new CEO to try and right the ship. The company also recently lowered costs for some customers for Isuprel and Nitropress in its bid to win back good will from the government. Bill Ackman’s Pershing Square is one of the largest shareholders of Valeant and has been involved in unlocking value at the company.

Follow Bausch Health Companies Inc. (NYSE:BHC)
Trade (NYSE:BHC) Now!

Disclosure: none

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.